{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:31:52Z","timestamp":1761539512953,"version":"build-2065373602"},"reference-count":126,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T00:00:00Z","timestamp":1382054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The coordinated expression and interplay among lineage specific transcription factors and microRNAs contribute to the regulation of gene expression and determination of cell specificity. In hematopoietic stem cells (HSCs), unique combinations of transcription factors largely control growth and maturation of different blood cell lineages through cooperative regulation of specific target genes. MicroRNAs provide an additional level of control beyond transcription factors. By acting as regulators of crucial lineage-specific genetic programs, microRNAs direct early multipotential progenitor cells to adopt a certain cell fate program. Thus, alteration of specific microRNA levels may affect proliferation, differentiation and genetic stability of HSCs, contributing to the onset of myeloproliferative disorders and leukemia. The major aim of this review is to highlight the critical role of microRNA-regulated pathways during the establishment and progression of hematological malignancies, with a particular attention to leukemia, lymphomas and myelodysplastic syndromes. This will give us the opportunity to discuss the potential use of microRNA-based therapeutic approaches in these diseases. MicroRNAs are indeed emerging as relevant tools to improve the efficacy of currently used therapeutic protocols.<\/jats:p>","DOI":"10.3390\/ijms141020930","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T12:05:51Z","timestamp":1382097951000},"page":"20930-20953","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["MicroRNA-Regulated Pathways in Hematological Malignancies: How to Avoid Cells Playing Out of Tune"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0743-7905","authenticated-orcid":false,"given":"Alessandro","family":"Fatica","sequence":"first","affiliation":[{"name":"Department of Biology and Biotechnology \"Charles Darwin\", Sapienza University of Rome,  Rome 00185, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2910-7912","authenticated-orcid":false,"given":"Francesco","family":"Fazi","sequence":"additional","affiliation":[{"name":"Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina 04100, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2013,10,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: Target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nrm1644","article-title":"MicroRNA biogenesis: Coordinated cropping and dicing","volume":"6","author":"Kim","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrm2632","article-title":"Biogenesis of small RNAs in animals","volume":"10","author":"Kim","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrg3471","article-title":"Adult-specific functions of animal microRNAs","volume":"14","author":"Sun","year":"2013","journal-title":"Nat. Rev. Genet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrc989","article-title":"Disruption of differentiation in human cancer: AML shows the way","volume":"3","author":"Tenen","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature10888","article-title":"The microcosmos of cancer","volume":"482","author":"Lujambio","year":"2012","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6687","DOI":"10.1038\/sj.onc.1210754","article-title":"Hematopoietic developmental pathways: On cellular basis","volume":"26","author":"Iwasaki","year":"2007","journal-title":"Oncogene"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.stem.2012.01.006","article-title":"Hematopoiesis: A human perspective","volume":"10","author":"Doulatov","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nri2024","article-title":"Transcription factors in myeloid development: Balancing differentiation with transformation","volume":"7","author":"Rosenbauer","year":"2007","journal-title":"Nat. Rev. Immunol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2012.04.005","article-title":"Roles for microRNAs in conferring robustness to biological processes","volume":"149","author":"Ebert","year":"2012","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ni.f.209","article-title":"MicroRNAs: New regulators of immune cell development and function","volume":"9","author":"Baltimore","year":"2008","journal-title":"Nat. Immunol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nri2708","article-title":"Physiological and pathological roles for microRNAs in the immune system","volume":"10","author":"Rao","year":"2010","journal-title":"Nat. Rev. Immunol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/0008-5472.CAN-03-3773","article-title":"Identification and characterization of a novel gene, C13orf25, as a target for 13q31\u2013q32 amplification in malignant lymphoma","volume":"64","author":"Ota","year":"2004","journal-title":"Cancer Res"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","article-title":"A microRNA polycistron as a potential human oncogene","volume":"435","author":"He","year":"2005","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1101\/gad.1872909","article-title":"Genetic dissection of the miR-17-92 cluster of microRNAs in Myc-induced B-cell lymphomas","volume":"23","author":"Mu","year":"2009","journal-title":"Genes Dev"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni1575","article-title":"Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes","volume":"9","author":"Xiao","year":"2008","journal-title":"Nat. Immunol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ncb2037","article-title":"Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukemia","volume":"12","author":"Mavrakis","year":"2010","journal-title":"Nat. Cell Biol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1038\/emboj.2011.317","article-title":"Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation","volume":"30","author":"Pospisil","year":"2011","journal-title":"EMBO J"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/ncb1613","article-title":"MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation","volume":"9","author":"Fontana","year":"2007","journal-title":"Nat. Cell. Biol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/cdd.2013.92","article-title":"Hoxb8 regulates expression of microRNAs to control cell death and differentiation","volume":"20","author":"Salmanidis","year":"2013","journal-title":"Cell Death Differ"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/MCB.01977-07","article-title":"MicroRNAs in the miR-106b family regulate p21\/CDKN1A and promote cell cycle progression","volume":"28","author":"Ivanovska","year":"2008","journal-title":"Mol. Cell. Biol"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1182\/blood-2008-03-147645","article-title":"MYC stimulates EZH2 expression by repression of its negative regulator miR-26a","volume":"112","author":"Sander","year":"2008","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1038\/cddis.2012.151","article-title":"The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells","volume":"3","author":"Salvatori","year":"2012","journal-title":"Cell Death Dis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ng.858","article-title":"A cooperative microRNA-tumour suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)","volume":"43","author":"Mavrakis","year":"2011","journal-title":"Nat. Genet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood-2009-09-243147","article-title":"microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma","volume":"115","author":"Zhao","year":"2010","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1182\/blood-2008-07-170589","article-title":"MicroRNA-29b induces global DNA hypomethylation and tumour suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1","volume":"113","author":"Garzon","year":"2009","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1182\/blood-2009-03-211938","article-title":"MicroRNA 29b functions in acute myeloid leukemia","volume":"114","author":"Garzon","year":"2009","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbrc.2011.09.063","article-title":"Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1","volume":"414","author":"Zhang","year":"2011","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ccr.2010.03.008","article-title":"Sp1\/NFkappaB\/HDAC\/miR-29b regulatory network in KIT-driven myeloid leukemia","volume":"17","author":"Liu","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1158\/0008-5472.CAN-08-3404","article-title":"miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia","volume":"69","author":"Pigazzi","year":"2009","journal-title":"Cancer Res"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1182\/blood-2010-04-281600","article-title":"C\/EBP\u03b1 regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations","volume":"116","author":"Pulikkan","year":"2010","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1038\/leu.2009.125","article-title":"miR-34b\/miR-34c: A regulator of TCL1 expression in 11q-chronic lymphocytic leukemia?","volume":"23","author":"Cardinaud","year":"2009","journal-title":"Leukemia"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1158\/0008-5472.CAN-10-4452","article-title":"Nicotinamide blocks proliferation and induces apoptosis ofchronic lymphocytic leukemia cells through activation of the p53\/miR-34a\/SIRT1 tumour suppressor network","volume":"71","author":"Audrito","year":"2011","journal-title":"Cancer Res"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1182\/blood-2010-06-289058","article-title":"Enforced expression of miR-125b affects myelopoiesis by targeting multiple signaling pathways","volume":"117","author":"Surdziel","year":"2011","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"21558","DOI":"10.1073\/pnas.1016611107","article-title":"MicroRNA miR-125b causes leukemia","volume":"107","author":"Bousquet","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"14235","DOI":"10.1073\/pnas.1009798107","article-title":"MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output","volume":"107","author":"Chaudhuri","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1073\/pnas.1200677109","article-title":"Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A","volume":"109","author":"Chaudhuri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"16636","DOI":"10.1073\/pnas.1213196109","article-title":"Complex oncogene dependence in microRNA-125a-induced myeloproliferative neoplasms","volume":"109","author":"Guo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"41961","DOI":"10.1074\/jbc.M110.169607","article-title":"Identification of microRNAs regulating reprogramming factor LIN28 in embryonic stem cells and cancer cells","volume":"285","author":"Zhong","year":"2010","journal-title":"J. Biol. Chem"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1084\/jem.20101823","article-title":"miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice","volume":"208","author":"Boldin","year":"2011","journal-title":"J. Exp. Med"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"9184","DOI":"10.1073\/pnas.1105398108","article-title":"NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies","volume":"108","author":"Zhao","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/path.1825","article-title":"BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas","volume":"207","author":"Kluiver","year":"2005","journal-title":"J. Pathol"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"20047","DOI":"10.1073\/pnas.1213764109","article-title":"miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the E\u03bc-miR-155 transgenic mouse model","volume":"109","author":"Sandhu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1073\/pnas.0902636106","article-title":"Inositol phosphatase SHIP1 is a primary target of miR-155","volume":"106","author":"Chaudhuri","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1200\/JCO.2012.45.6228","article-title":"Clinical Role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients","volume":"31","author":"Marcucci","year":"2013","journal-title":"J. Clin. Oncol"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cell.2005.09.023","article-title":"A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C\/EBPalpha regulates human granulopoiesis","volume":"123","author":"Fazi","year":"2005","journal-title":"Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1182\/blood-2009-08-240101","article-title":"Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia","volume":"115","author":"Pulikkan","year":"2010","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.20122516","article-title":"The TAL1 complex targets the FBXW7 tumour suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia","volume":"210","author":"Mansour","year":"2013","journal-title":"J. Exp. Med"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.cell.2010.01.007","article-title":"miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts","volume":"140","author":"Eiring","year":"2010","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1038\/sj.onc.1205400","article-title":"The proto-oncogene c-myc in hematopoietic development and leukemogenesis","volume":"21","author":"Hoffman","year":"2002","journal-title":"Oncogene"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng.2007.30","article-title":"Widespread microRNA repression by Myc contributes to tumourigenesis","volume":"40","author":"Chang","year":"2008","journal-title":"Nat. Genet"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.167.2.353","article-title":"The E\u03bc-Myc transgenic mouse: A model for high-incidence spontaneous lymphoma and leukemia of early B cells","volume":"167","author":"Harris","year":"1988","journal-title":"J. Exp. Med"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1182\/blood-2005-02-0734","article-title":"c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations","volume":"106","author":"Luo","year":"2005","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/1947601911416357","article-title":"Critical role of c-Myc in acute myeloid leukemia involving direct regulation of miR-26a and histone methyltransferase EZH2","volume":"2","author":"Salvatori","year":"2011","journal-title":"Genes Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Zhao, X., Lwin, T., Zhang, X., Huang, A., Wang, J., Marquez, V.E., Chen-Kiang, S., Dalton, W.S., Sotomayor, E., and Tao, J (2013). Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity. Leukemia.","DOI":"10.1038\/leu.2013.94"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.gde.2004.02.001","article-title":"The functions of E(Z)\/EZH2-mediated methylation of lysine 27 in histone H3","volume":"14","author":"Cao","year":"2004","journal-title":"Curr. Opin. Genet. Dev"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1093\/nar\/gkr1278","article-title":"MicroRNA-26a\/b and their host genes cooperate to inhibit the G1\/S transition by activating the pRb protein","volume":"40","author":"Zhu","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/onc.2011.208","article-title":"miR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumour suppressor in acute myeloid leukemia","volume":"31","author":"Zheng","year":"2012","journal-title":"Oncogene"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.cell.2009.04.021","article-title":"Therapeutic microRNA delivery suppresses tumourigenesis in a murine liver cancer model","volume":"137","author":"Kota","year":"2009","journal-title":"Cell"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1073\/pnas.0909896107","article-title":"Integrative genome analysis reveals an oncomir\/oncogene cluster regulating glioblastoma survivorship","volume":"107","author":"Kim","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1182\/blood-2011-10-385716","article-title":"MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia","volume":"119","author":"Wang","year":"2012","journal-title":"Blood"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1084\/jem.20090831","article-title":"MicroRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia","volume":"207","author":"Han","year":"2010","journal-title":"J. Exp. Med"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood-2011-05-351510","article-title":"Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia","volume":"119","author":"Sampath","year":"2012","journal-title":"Blood"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1158\/0008-5472.CAN-06-3613","article-title":"Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181","volume":"66","author":"Pekarsky","year":"2006","journal-title":"Cancer Res"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"12210","DOI":"10.1073\/pnas.1007186107","article-title":"Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression","volume":"107","author":"Santanam","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","first-page":"935","article-title":"MicroRNAs and RNA-binding proteins: A complex network of interactions and reciprocal regulations in cancer","volume":"10","author":"Galardi","year":"2013","journal-title":"RNA Biol"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ccr.2012.09.003","article-title":"Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas","volume":"22","author":"Zhang","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/carcin\/bgq033","article-title":"Epigenetic inactivation of the miR-34a in hematological malignancies","volume":"31","author":"Chim","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/cdd.2009.56","article-title":"The miR-34 family in cancer and apoptosis","volume":"17","author":"Hermeking","year":"2010","journal-title":"Cell Death Differ"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1182\/blood-2012-10-458695","article-title":"Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients","volume":"121","author":"Dufour","year":"2013","journal-title":"Blood"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1182\/blood-2008-08-172254","article-title":"miR-34a as part of the resistance network in chronic lymphocytic leukemia","volume":"113","author":"Zenz","year":"2009","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1158\/1535-7163.MCT-11-0152","article-title":"Restitution of tumour suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice","volume":"10","author":"Pramanik","year":"2011","journal-title":"Mol. Cancer Ther"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.2284","article-title":"The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44","volume":"17","author":"Liu","year":"2011","journal-title":"Nat. Med"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/mt.2011.48","article-title":"Systemic delivery of tumour suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumours in mice","volume":"19","author":"Trang","year":"2011","journal-title":"Mol. Ther"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1182\/blood-2011-02-335141","article-title":"Macrophage development from HSCs requires PU.1-coordinated microRNA expression","volume":"118","author":"Ghani","year":"2011","journal-title":"Blood"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2009-06-225987","article-title":"An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes","volume":"115","author":"Curtale","year":"2010","journal-title":"Blood"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/emmm.201100136","article-title":"Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers","volume":"3","author":"Garcia","year":"2011","journal-title":"EMBO Mol. Med"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/imr.12043","article-title":"The Yin and Yang of microRNAs: Leukemia and immunity","volume":"253","author":"So","year":"2013","journal-title":"Immunol. Rev"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood-2008-12-196196","article-title":"NFI-A directs the fate of hematopoietic progenitors to the erythroid or granulocytic lineage and controls beta-globin and G-CSF receptor expression","volume":"114","author":"Starnes","year":"2009","journal-title":"Blood"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/blood-2011-08-371344","article-title":"Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression","volume":"119","author":"Zardo","year":"2007","journal-title":"Blood"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ccr.2007.09.020","article-title":"Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1\/ETO oncoprotein","volume":"12","author":"Fazi","year":"2007","journal-title":"Cancer Cell"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PPO.0b013e318258b60a","article-title":"The microRNA-17-92 family of microRNA clusters in development and disease","volume":"18","author":"Concepcion","year":"2012","journal-title":"Cancer J"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","article-title":"c-Myc-regulated microRNAs modulate E2F1 expression","volume":"435","author":"Wentzel","year":"2005","journal-title":"Nature"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1074\/jbc.C600252200","article-title":"Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors","volume":"282","author":"Woods","year":"2007","journal-title":"J. Biol. Chem"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1074\/jbc.M608939200","article-title":"An E2F\/miR-20a autoregulatory feedback loop","volume":"282","author":"Sylvestre","year":"2007","journal-title":"J. Biol. Chem"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cell.2008.02.019","article-title":"Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters","volume":"132","author":"Ventura","year":"2008","journal-title":"Cell"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/leu.2011.305","article-title":"The miRNA-17-92 cluster mediates chemoresistance and enhances tumour growth in mantle cell lymphoma via PI3K\/AKT pathway activation","volume":"26","author":"Rao","year":"2012","journal-title":"Leukemia"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"15535","DOI":"10.1073\/pnas.0808266105","article-title":"Distinct microRNA expression profiles in acute myeloid leukemia with common translocations","volume":"105","author":"Li","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1158\/0008-5472.CAN-09-3268","article-title":"The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression","volume":"70","author":"Wong","year":"2010","journal-title":"Cancer Res"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e2236","DOI":"10.1371\/journal.pone.0002236","article-title":"Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM","volume":"3","author":"Fontana","year":"2008","journal-title":"PLoS One"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/leu.2012.90","article-title":"miR-125 in normal and malignant hematopoiesis","volume":"26","author":"Shaham","year":"2012","journal-title":"Leukemia"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"38253","DOI":"10.1074\/jbc.M111.269670","article-title":"miR-125b, a target of CDX2, regulates cell differentiation through repression of the core binding factor in hematopoietic malignancies","volume":"286","author":"Lin","year":"2011","journal-title":"J. Biol. Chem"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.immuni.2009.06.024","article-title":"The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs","volume":"31","author":"Androulidaki","year":"2009","journal-title":"Immunity"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.0610731104","article-title":"MicroRNA-155 is induced during the macrophage inflammatory response","volume":"104","author":"Taganov","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1074\/jbc.M708218200","article-title":"B-cell receptor activation induces BIC\/miR-155 expression through a conserved AP-1 element","volume":"283","author":"Yin","year":"2008","journal-title":"J. Biol. Chem"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1096\/fj.09-131342","article-title":"LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages","volume":"23","author":"Ruggiero","year":"2009","journal-title":"FASEB J"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1073\/pnas.0500613102","article-title":"Accumulation of miR-155 and BIC RNA in human B cell lymphomas","volume":"102","author":"Eis","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1073\/pnas.0602266103","article-title":"Pre-B cell proliferation and lymphoblastic leukemia\/high-grade lymphoma in E(mu)-miR155 transgenic mice","volume":"103","author":"Costinean","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.20072108","article-title":"Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder","volume":"205","author":"Rao","year":"2008","journal-title":"J. Exp. Med"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Faraoni, I., Laterza, S., Ardiri, D., Ciardi, C., Fazi, F., and Lo-Coco, F (2012). miR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: Correlation with NPM1 and FLT3 mutation status. J. Hematol. Oncol, 5.","DOI":"10.1186\/1756-8722-5-26"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2013.48.8239","article-title":"MicroRNA dysregulation in acute myeloid leukemia","volume":"31","author":"Croce","year":"2013","journal-title":"J. Clin. Oncol"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.1093\/nar\/gkq337","article-title":"HOXA9 regulates miR-155 in hematopoietic cells","volume":"38","author":"Hu","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"E1695","DOI":"10.1073\/pnas.1201516109","article-title":"Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma","volume":"109","author":"Babar","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood-2009-05-220814","article-title":"Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-miR-155 transgenic mice","volume":"114","author":"Costinean","year":"2009","journal-title":"Blood"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood-2012-02-410647","article-title":"LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas","volume":"120","author":"Zhang","year":"2012","journal-title":"Blood"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.cub.2004.11.012","article-title":"An Mll-dependent Hox program drives hematopoietic progenitor expansion","volume":"14","author":"Ernst","year":"2004","journal-title":"Curr. Biol"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1097-2765(02)00741-4","article-title":"MLL targets SET domain methyltransferase activity to Hox gene promoters","volume":"10","author":"Milne","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"7517","DOI":"10.1073\/pnas.0800090105","article-title":"MLL protects CpG clusters from methylation within the Hoxa9 gene, maintaining transcript expression","volume":"105","author":"Erfurth","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng765","article-title":"MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia","volume":"30","author":"Armstrong","year":"2002","journal-title":"Nat. Genet"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"11367","DOI":"10.1158\/0008-5472.CAN-05-1041","article-title":"Leukemogenic MLL fusion proteins bind across a broad region of the Hoxa9 locus, promoting transcription and multiple histone modifications","volume":"65","author":"Milne","year":"2005","journal-title":"Cancer Res"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1182\/blood-2008-04-154310","article-title":"Regulation of miR-196b by MLL and its overexpression by MLL fusions contributes to immortalization","volume":"113","author":"Popovic","year":"2009","journal-title":"Blood"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Li, Z., Huang, H., Chen, P., He, M., Li, Y., Arnovitz, S., Jiang, X., He, C., Hyjek, E., and Zhang, J. (2012). miR-196b directly targets both Hoxa9\/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat. Commun, 3.","DOI":"10.1038\/ncomms1681"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3324\/haematol.2010.023481","article-title":"Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of Hoxa genes in pediatric acute lymphoblastic leukemia","volume":"95","author":"Schotte","year":"2010","journal-title":"Haematologica"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00432-011-1137-3","article-title":"miR-181a sensitizes resistant leukaemia HL-60\/Ara-C cells to Ara-C by inducing apoptosis","volume":"138","author":"Bai","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.1158\/0008-5472.CAN-11-1717","article-title":"MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of Ara-C-induced apoptosis","volume":"71","author":"Gocek","year":"2011","journal-title":"Cancer Res"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1038\/sj.onc.1205699","article-title":"5-Azacytidine and 5-aza-2\u2032-deoxycytidine as inhibitors of DNA methylation: Mechanistic studies and their implications for cancer therapy","volume":"21","author":"Christman","year":"2002","journal-title":"Oncogene"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1073\/pnas.1002650107","article-title":"Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine","volume":"107","author":"Blum","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/leu.2012.342","article-title":"Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: A novel epigenetic-targeting approach in acute myeloid leukemia","volume":"27","author":"Mims","year":"2013","journal-title":"Leukemia"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1158\/1078-0432.CCR-12-3191","article-title":"Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: A novel therapeutic strategy in acute myeloid leukemia","volume":"19","author":"Huang","year":"2013","journal-title":"Clin. Cancer Res"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.18632\/oncotarget.675","article-title":"DNA-demethylating and anti-tumour activity of synthetic miR-29b mimics in multiple myeloma","volume":"3","author":"Amodio","year":"2012","journal-title":"Oncotarget"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccr.2008.04.018","article-title":"Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression","volume":"13","author":"Bueno","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ccr.2008.05.013","article-title":"Linking miRNA regulation to BCR-ABL expression: The next dimension","volume":"13","author":"Faber","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.leukres.2013.07.019","article-title":"Imatinib induces demethylation of miR-203 gene: An epigenetic mechanism of anti-tumor effect of imatinib","volume":"37","author":"Shibuta","year":"2013","journal-title":"Leuk. Res"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrc3166","article-title":"Epigenetics and genetics. MicroRNAs en route to the clinic: Progress in validating and targeting microRNAs for cancer therapy","volume":"11","author":"Kasinski","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cell.2013.02.012","article-title":"Long noncoding RNAs: Cellular address codes in development and disease","volume":"152","author":"Batista","year":"2013","journal-title":"Cell"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/10\/20930\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:49:58Z","timestamp":1760219398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/10\/20930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,18]]},"references-count":126,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10]]}},"alternative-id":["ijms141020930"],"URL":"https:\/\/doi.org\/10.3390\/ijms141020930","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2013,10,18]]}}}